Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Category: Oncotarget

Oncotarget

NSD2 Gene Drives Cancer Cell Identity in Multiple Myeloma

April 2, 2025

“Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic strategies based on targeting of NSD2.” BUFFALO, NY - April 2, 2025… read more

Oncotarget

Single Protein Mimics Retinoic Acid Therapy to Help Leukemia Cells Mature

March 31, 2025

"This study reveals that the expression of the Src-family kinase (SFK), FGR, alone can induce cell differentiation similar to RA.” BUFFALO, NY - March 31, 2025 – A new research… read more

Oncotarget

Why Some Breast Cancer Treatments Stop Working

March 25, 2025

"Innovations in therapeutic strategies, coupled with a deeper understanding of breast cancer biology, will be essential for advancing personalized medicine and improving clinical outcomes.” BUFFALO, NY - March 25, 2025… read more

Oncotarget

Clear Scans Can Be Misleading: Residual Cancer Linked to Worse Outcomes

March 21, 2025

"SABR is a well-established therapy in both the curative and metastatic setting, however, its ablative potential may not be as high as suggested by radiographic local control rates.” BUFFALO, NY… read more

Oncotarget

WIN Consortium Leading the Future of Precision Cancer Medicine

March 18, 2025

"Our vision is to accelerate the future of precision oncology care.” BUFFALO, NY - March 18, 2025 – A new precision oncology paper was published in Oncotarget, Volume 16, on… read more

Oncotarget

Oncotarget to Participate at the AACR Annual Meeting 2025

March 17, 2025

Oncotarget is honored to participate in the American Association for Cancer Research (AACR) Annual Meeting 2025, scheduled for April 25-30 in Chicago. BUFFALO, NY - March 17, 2025 – Impact… read more

Oncotarget

Rethinking Breast Cancer Screening: New Insights on Overdiagnosis

March 12, 2025

"These suggest that not an insignificant proportion of invasive cancers may also be overdiagnosed as indolent cancers with a very long lead time or cancers that spontaneously regress.” BUFFALO, NY… read more